Ubs Group Ag Kazia Therapeutics LTD Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Ubs Group Ag holds 249,452 shares of KZIA stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

249,452

Previous 23,336 968.96%

Holding current value

$1.44 Million

Previous $5,000 2040.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.19 - $1.24 $42,962 - $280,383	226,116 Added 968.96%	249,452 $107,000
Q2 2024 Aug 13, 2024	BUY	$0.2 - $0.46 $4,667 - $10,734	23,336 New	23,336 $5,000
Q4 2023 Feb 09, 2024	BUY	$0.39 - $0.99 $39 - $99	100 New	100 $0
Q4 2022 Feb 08, 2023	BUY	$0.5 - $1.23 $1,248 - $3,070	2,496 Added 64.71%	6,353 $3,000
Q3 2022 Nov 10, 2022	BUY	$1.1 - $4.19 $1,525 - $5,811	1,387 Added 56.15%	3,857 $4,000
Q2 2022 Aug 10, 2022	BUY	$4.1 - $8.38 $10,127 - $20,698	2,470 New	2,470 $10,000
Q1 2022 May 16, 2022	SELL	$6.05 - $8.65 $18,452 - $26,382	-3,050 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.35 - $12.0 $19,440 - $31,740	2,645 Added 653.09%	3,050 $26,000
Q3 2021 Nov 15, 2021	BUY	$8.65 - $11.64 $3,503 - $4,714	405 New	405 $5,000
Q2 2021 Aug 13, 2021	SELL	$9.1 - $14.71 $14,705 - $23,771	-1,616 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$8.98 - $12.86 $11,090 - $15,882	-1,235 Reduced 43.32%	1,616 $20,000
Q4 2020 Feb 11, 2021	BUY	$5.61 - $13.47 $8,583 - $20,609	1,530 Added 115.82%	2,851 $25,000
Q3 2020 Nov 12, 2020	BUY	$3.33 - $8.26 $4,065 - $10,085	1,221 Added 1221.0%	1,321 $9,000
Q2 2020 Jul 31, 2020	SELL	$2.56 - $3.6 $21,911 - $30,812	-8,559 Reduced 98.85%	100 $0
Q1 2020 May 01, 2020	BUY	$2.72 - $4.64 $19,401 - $33,097	7,133 Added 467.43%	8,659 $25,000
Q4 2019 Feb 14, 2020	BUY	$2.84 - $7.4 $4,049 - $10,552	1,426 Added 1426.0%	1,526 $6,000
Q3 2019 Nov 14, 2019	SELL	$2.33 - $3.83 $1,551 - $2,550	-666 Reduced 86.95%	100 $0
Q2 2019 Aug 14, 2019	SELL	$2.31 - $3.58 $1,801 - $2,792	-780 Reduced 50.45%	766 $2,000
Q1 2019 May 14, 2019	SELL	$2.27 - $3.9 $5,556 - $9,547	-2,448 Reduced 61.29%	1,546 $5,000
Q4 2018 Feb 14, 2019	SELL	$2.2 - $3.18 $4,543 - $6,566	-2,065 Reduced 34.08%	3,994 $9,000
Q3 2018 Nov 14, 2018	SELL	$3.05 - $3.9 $1,171 - $1,497	-384 Reduced 5.96%	6,059 $20,000
Q2 2018 Aug 14, 2018	BUY	$2.9 - $5.9 $15,900 - $32,349	5,483 Added 571.15%	6,443 $19,000
Q1 2018 May 15, 2018	SELL	$2.88 - $6.25 $6,027 - $13,081	-2,093 Reduced 68.56%	960 $5,000
Q4 2017 Feb 14, 2018	BUY	$2.4 - $3.41 $7,327 - $10,410	3,053	3,053 $10,000

Others Institutions Holding KZIA

# of Institutions

Shares Held

2.13M

Call Options Held

93.2K

Put Options Held

View Full List

About KAZIA THERAPEUTICS LTD

Ticker KZIA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,111,300
Market Cap $87.5M
Description
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...

More about KZIA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account